Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers
Safiye Akkın, Gamze Varan, Erem Bilensoy
Molecules (2021) Vol. 26, Iss. 11, pp. 3382-3382
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Potential mechanisms by which oleanic and maslinic acids from Cola lateritia K. Schum (Sterculiaceae) twigs inhibit prostate cancer cell growth
Michael Hermann Kengne Kamdem, Timothy Grein, Kevine Kamga Silihe, et al.
South African Journal of Botany (2025) Vol. 181, pp. 52-66
Closed Access
Impact of Chitosan Nanoparticles-Coated Dendritic Cell-Based Vaccine as Cancer Immunotherapy
Jehan Alrahimi, Najla Alotaibi, Alia Aldahlawi, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 474-474
Open Access
Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine
Elisabetta Canetta
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13141-13141
Open Access | Times Cited: 24
Multimodal Imaging and Phototherapy of Cancer and Bacterial Infection by Graphene and Related Nanocomposites
Ganesh Gollavelli, Anil V. Ghule, Yong‐Chien Ling
Molecules (2022) Vol. 27, Iss. 17, pp. 5588-5588
Open Access | Times Cited: 17
Can Immune Therapy Cure Acute Myeloid Leukemia?
Robert Peter Gale
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 5, pp. 381-386
Open Access | Times Cited: 9
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
Fatai Lu, Yingkang Zhu, Guodong Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer
Safiye Akkın, Gamze Varan, Anıl Işık, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 314-314
Open Access | Times Cited: 7
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
Xing He, Huanrong Lan, Ketao Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Polyethylenimine grafted-chitosan based Gambogic acid copolymers for targeting cancer cells overexpressing transferrin receptors
Seong‐Cheol Park, Hun Heo, Mi-Kyeong Jang
Carbohydrate Polymers (2021) Vol. 277, pp. 118755-118755
Closed Access | Times Cited: 16
Nanocarriers targeting the diseases of the pancreas
Nurbanu Demirtürk, Erem Bilensoy
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 170, pp. 10-23
Closed Access | Times Cited: 15
Calorie restriction and breast cancer treatment: a mini-review
Meden F. Isaac-Lam, Kelly DeMichael
Journal of Molecular Medicine (2022) Vol. 100, Iss. 8, pp. 1095-1109
Closed Access | Times Cited: 10
Hollow MnO2 Nanoparticles Loaded with Functional Genes as Nanovaccines for Synergistic Cancer Therapy
Weicai Wang, Xiaozu Chen, Junwei Li, et al.
ACS Applied Nano Materials (2022) Vol. 5, Iss. 8, pp. 10537-10547
Closed Access | Times Cited: 10
Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment
Balázs Kiss, János Borbély
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1761-1761
Open Access | Times Cited: 6
Pembrolizumab alone or in combination with chemotherapy versus chemotherapy for advanced gastric cancer: A cost‐effectiveness analysis
Yitian Lang, Yan Lin, Dan Li, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18447-18459
Open Access | Times Cited: 6
Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma
Dandan Xiong, Jian‐Di Li, Rong‐Quan He, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4938-4950
Open Access | Times Cited: 9
Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential
Jordan D. Lewicky, Alexandrine L. Martel, Mukul R. Gupta, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4127-4127
Open Access | Times Cited: 5
Gestational Breast Cancer – a Review of Outcomes, Pathophysiology, and Model Systems
Mackenzie K. Callaway, Camila O. dos Santos
Journal of Mammary Gland Biology and Neoplasia (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Duguetia confinis Engl. & Diels (Annonaceae) inhibitory and cytotoxic effects on breast adenocarcinoma growth both in vitro and in vivo
Ornella Bernie Kami Nkuimi, Kevine Kamga Silihe, Yves Omgba Tabi, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24410-e24410
Open Access | Times Cited: 1
Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer
Yitian Lang, Yan Lin, Meng Deng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Research Progress of Imaging Histology in the Prognosis of Ovarian Cancer Immunotherapy
子金 郑
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 759-766
Closed Access | Times Cited: 1
Photothermal Depth Profiling of Gelatin-Stabilised Gold Nanorods-Trastuzumab Conjugate as a Potential Breast Cancer Photothermal Agent
Gracia It Mwad Mbaz, Thabang Calvin Lebepe, Rodney Maluleke, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2024)
Open Access | Times Cited: 1
Design, synthesis, anticancer and in silico assessment of 8-caffeinyl chalcone hybrid conjugates
Mohammad Navid Soltani Rad, Somayeh Behrouz, Maedeh Charbaghi, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26674-26693
Open Access | Times Cited: 1
Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
Um‐e‐Kalsoom, Shiqi Wang, Junle Qu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 19
Open Access | Times Cited: 1
Exploring the Immunoresponse in Bladder Cancer Immunotherapy
Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1937-1937
Open Access | Times Cited: 1
Activated T cell therapy targeting glioblastoma cancer stem cells
Ken Miyaguchi, Hongqiang Wang, Keith L. Black, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Scroll to top